Binyang Chen Selected Research

mastoparan M

1/2023

Mastoparan M Suppressed NLRP3 Inflammasome Activation by Inhibiting MAPK/NF-κB and Oxidative Stress in Gouty Arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Binyang Chen Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 01/2022
2	Insulin Resistance 01/2022 - 01/2022
1	Atherosclerotic Plaque (Atheroma) 09/2023
1	Atherosclerosis 09/2023
1	Gouty Arthritis 01/2023
1	Glucose Intolerance 01/2022
1	Hyperuricemia 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Obesity 01/2022

Drug/Important Bio-Agent (IBA)

4	Uric Acid (Urate)IBA 09/2023 - 01/2022
2	LipidsIBA 09/2023 - 01/2022
2	Advanced Glycation End ProductsIBA 01/2022 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2022
1	oil red OIBA 09/2023
1	CollagenIBA 09/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2023
1	Hematoxylin (Haematoxylon)IBA 09/2023
1	InflammasomesIBA 01/2023
1	mastoparan MIBA 01/2023
1	Insulin (Novolin)FDA Link 01/2022
1	purineIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Pattern Recognition ReceptorsIBA 01/2022
1	2- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA 01/2022

Therapy/Procedure

1	Intra-Articular Injections 01/2023